文献检索文档翻译深度研究

邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

不再提醒

插件&应用

Zotero 插件浏览器插件 Mac 客户端 Windows 客户端微信小程序

高级版

套餐订阅购买积分包

AI 工具

文献检索文档翻译深度研究

关于我们

关于 Suppr 公司介绍联系我们用户协议隐私条款

关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究

粤ICP备2023148730 号-1Suppr @ 2025

The potential effects of newer groups of glucose lowering drugs on age-related macular degeneration.

作者信息

Ebrahimi Moein, Sivaprasad Sobha

机构信息

School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Network of Immunity in Infection, Malignancy, and Autoimmunity, Universal Scientific Education and Research Network (USERN), Tehran, Iran.

出版信息

Eye (Lond). 2024 Sep;38(13):2649-2650. doi: 10.1038/s41433-024-03066-5. Epub 2024 Apr 11.

DOI:10.1038/s41433-024-03066-5

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11383937/

Abstract

摘要

相似文献

[1]

The potential effects of newer groups of glucose lowering drugs on age-related macular degeneration.

Eye (Lond). 2024-9

[2]

Disease latency bias and the protective effect of metformin against age-related macular degeneration.

Eye (Lond). 2024-10

[3]

Photodynamic therapy for neovascular age-related macular degeneration.

Cochrane Database Syst Rev. 2003

[4]

Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease.

Cochrane Database Syst Rev. 2018-9-24

[5]

Glucagon-like Peptide-1 Receptor Agonist Impact on Chronic Ocular Disease Including Age-Related Macular Degeneration.

Ophthalmology. 2025-7

[6]

Newer glucose-lowering drugs reduce the risk of late-onset seizure and epilepsy: A meta-analysis.

Epilepsia Open. 2024-12

[7]

Metformin Use and Age-Related Macular Degeneration in Patients Without Diabetes.

JAMA Ophthalmol. 2024-1-1

[8]

Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.

Cochrane Database Syst Rev. 2017-2-27

[9]

Methodological Considerations for the Case-Control Study of Metformin and Age-Related Macular Degeneration.

JAMA Ophthalmol. 2021-8-1

[10]

The effect of the pandemic on the intravitreal injection treatment for patients with age-related macular degeneration, regardless of lockdown periods.

Rom J Ophthalmol. 2025

引用本文的文献

[1]

Glucagon-Like Peptide-1 Receptor Agonists and Risk of Neovascular Age-Related Macular Degeneration.

JAMA Ophthalmol. 2025-6-5

[2]

Use of SGLT2 Inhibitors Versus DPP-4 Inhibitors and Age-Related Macular Degeneration in Patients WithType 2 Diabetes: A Multinational Cohort Study.

Invest Ophthalmol Vis Sci. 2025-4-1

[3]

Shared signaling pathways and comprehensive therapeutic approaches among diabetes complications.

Front Med (Lausanne). 2025-1-8

本文引用的文献

[1]

Melatonin Inhibits VEGF-Induced Endothelial Progenitor Cell Angiogenesis in Neovascular Age-Related Macular Degeneration.

Cells. 2023-3-3

[2]

Association between oral metformin use and the risk of age-related macular degeneration: A systematic review with meta-analysis.

Acta Ophthalmol. 2023-9

[3]

Associations Between HbA1c Across the Normal Range, Diagnosed, and Undiagnosed Diabetes and Retinal Layer Thickness in UK Biobank Cohort.

Transl Vis Sci Technol. 2023-2-1

[4]

Effects of systemic drugs on the development and progression of age-related macular degeneration.

Surv Ophthalmol. 2023

[5]

Antioxidant Effects of DPP-4 Inhibitors in Early Stages of Experimental Diabetic Retinopathy.

Antioxidants (Basel). 2022-7-21

[6]

Novel and investigational therapies for wet and dry age-related macular degeneration.

Drug Discov Today. 2022-8

[7]

2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

J Am Coll Cardiol. 2022-5-3

[8]

Gene Set Enrichment Analsyes Identify Pathways Involved in Genetic Risk for Diabetic Retinopathy.

Am J Ophthalmol. 2022-1

[9]

Five-Year Outcomes after Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T Extension Study).

Ophthalmology. 2020-3-29

[10]

Use of Bevacizumab and Ranibizumab for Wet Age-Related Macular Degeneration: Influence of CATT Results and Introduction of Aflibercept.

Am J Ophthalmol. 2019-5-15

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

推荐工具

医学文档翻译智能文献检索